Skip to main content Help with accessibility Skip to main navigation

IVABRADINE (Procoralan®) for the treatment of chronic heart failure

CCG Approval Status:

Date Added: 31 - Jan - 2018
Body System:
Amber initiated

Ivabradine has been approved by NICE (TA 267)1 as an option for treating chronic heart failure following specialist initiation in patients with chronic, stable heart failure (NYHA class II-IV), left ventricular systolic dysfunction (LVEF 35% or less) and who are in sinus rhythm with a heart rate of 75 beats per minute or more.